| scholarly article | Q13442814 |
| P50 | author | Wei-Chi Ku | Q59540608 |
| Wei-Hsiang Hsu | Q91054939 | ||
| P2093 | author name string | Chung-Kuang Lu | |
| Yun-Lian Lin | |||
| Young-Ji Shiao | |||
| Ching-Hua Kuo | |||
| Yuh-Chiang Shen | |||
| Tai-Yuan Lin | |||
| P2860 | cites work | Metabolite profiling of Alzheimer's disease cerebrospinal fluid | Q28480903 |
| Multiplex Brain Proteomic Analysis Revealed the Molecular Therapeutic Effects of Buyang Huanwu Decoction on Cerebral Ischemic Stroke Mice | Q28550456 | ||
| Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association | Q30238784 | ||
| Dkk-3 is elevated in CSF and plasma of Alzheimer's disease patients | Q33448926 | ||
| 1H NMR Analysis of Cerebrospinal Fluid from Alzheimer's Disease Patients: An Example of a Possible Misinterpretation Due to Non-Adjustment of pH | Q33601031 | ||
| MetPA: a web-based metabolomics tool for pathway analysis and visualization | Q33632049 | ||
| Characterization of individual mouse cerebrospinal fluid proteomes | Q33709259 | ||
| Recommendations for standards regarding preclinical neuroprotective and restorative drug development | Q33785562 | ||
| Dickkopf-related protein 3 is a potential Aβ-associated protein in Alzheimer's Disease | Q48105192 | ||
| Secretory sorting receptors carboxypeptidase E and secretogranin III in amyloid β-associated neural degeneration in Alzheimer's disease. | Q48368176 | ||
| Chitinase enzyme activity in CSF is a powerful biomarker of Alzheimer disease | Q48665932 | ||
| Are patients with cognitive impairment after stroke at increased risk for developing Alzheimer disease? | Q53262594 | ||
| Purine metabolites in the CSF in presenile and senile dementia of Alzheimer type, and in multi infarct dementia | Q53305162 | ||
| Amino acid concentrations in cerebrospinal fluid and serum in Alzheimer's disease and vascular dementia. | Q53317231 | ||
| Brain Extracellular Fluid Protein Changes in Acute Stroke Patients | Q58857961 | ||
| Cerebrospinal fluid taurine in alzheimer's disease | Q67809506 | ||
| Hypoxanthine, xanthine, urate and creatinine concentration gradients in cerebrospinal fluid | Q68054546 | ||
| Cerebrospinal fluid hypoxanthine, xanthine and uric acid levels may reflect glutamate-mediated excitotoxicity in different neurological diseases | Q74178691 | ||
| Tongqiao huoxue tang and buyang huanwu tang for treatment of vascular dementia--a report of 36 cases | Q75248698 | ||
| A response to The effects of vascular disease on late onset Parkinson's disease (Papapetropoulos et al.). | Q80302660 | ||
| Metabolic shifts in immunity and inflammation. | Q33829813 | ||
| Plasma proteome profiles associated with inflammation, angiogenesis, and cancer | Q33903921 | ||
| Innate inflammatory responses in stroke: mechanisms and potential therapeutic targets | Q33925611 | ||
| Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. | Q34157715 | ||
| Transient focal cerebral ischemia/reperfusion induces early and chronic axonal changes in rats: its importance for the risk of Alzheimer's disease | Q34211964 | ||
| Regulation of 4-hydroxynonenal-mediated signaling by glutathione S-transferases | Q34337854 | ||
| Wnt signaling enhances neurogenesis and improves neurological function after focal ischemic injury | Q34345281 | ||
| Tumor microenvironment-derived proteins dominate the plasma proteome response during breast cancer induction and progression | Q35141434 | ||
| Alzheimer lesions after ischemia-reperfusion brain injury | Q35944273 | ||
| Quantitative proteomic analysis of Niemann-Pick disease, type C1 cerebellum identifies protein biomarkers and provides pathological insight | Q36353769 | ||
| Clinical efficacy and safety of buyang huanwu decoction for acute ischemic stroke: a systematic review and meta-analysis of 19 randomized controlled trials | Q36379317 | ||
| APLP1 as a cerebrospinal fluid biomarker for γ-secretase modulator treatment | Q36393290 | ||
| PANTHER version 10: expanded protein families and functions, and analysis tools. | Q36434795 | ||
| Blood-brain barrier permeability is increased after acute adult stroke but not neonatal stroke in the rat. | Q36517224 | ||
| Protein changes in immunodepleted cerebrospinal fluid from a transgenic mouse model of Alexander disease detected using mass spectrometry | Q36599253 | ||
| Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease | Q36887148 | ||
| Increased levels of inosine in a mouse model of inflammation | Q37053873 | ||
| Metabolite profiling identifies a branched chain amino acid signature in acute cardioembolic stroke | Q37275361 | ||
| Efficacy and safety of tissue plasminogen activator 3 to 4.5 hours after acute ischemic stroke: a metaanalysis. | Q37301824 | ||
| A modern approach to CSF analysis: pathophysiology, clinical application, proof of concept and laboratory reporting. | Q37382847 | ||
| Biochemical, structural, and biomarker evidence for calpain-mediated cytoskeletal change after diffuse brain injury uncomplicated by contusion | Q37425364 | ||
| Wnt signalling and the control of cellular metabolism. | Q37708317 | ||
| Buyang Huanwu Decoction Ameliorates Poststroke Depression via Promoting Neurotrophic Pathway Mediated Neuroprotection and Neurogenesis | Q37714692 | ||
| Amyloid precursor protein processing and Alzheimer's disease | Q37860317 | ||
| Taurine and central nervous system disorders | Q38035753 | ||
| A multivariate predictive modeling approach reveals a novel CSF peptide signature for both Alzheimer's Disease state classification and for predicting future disease progression | Q38644393 | ||
| Minimal, encapsulated proteomic-sample processing applied to copy-number estimation in eukaryotic cells | Q39028018 | ||
| PKC-β exacerbates in vitro brain barrier damage in hyperglycemic settings via regulation of RhoA/Rho-kinase/MLC2 pathway | Q39107503 | ||
| Low-abundant cerebrospinal fluid proteome alterations in dementia with Lewy bodies | Q39500507 | ||
| Neuronal pentraxin receptor in cerebrospinal fluid as a potential biomarker for neurodegenerative diseases | Q39860782 | ||
| A technique for serial collection of cerebrospinal fluid from the cisterna magna in mouse | Q42584977 | ||
| Mouse-specific tandem IgY7-SuperMix immunoaffinity separations for improved LC-MS/MS coverage of the plasma proteome. | Q42672310 | ||
| Cerebrospinal fluid concentrations of creatinine and purine metabolites determined by high performance liquid chromatography: preliminary report on head injury and stroke patients | Q43452636 | ||
| (1)H NMR-based metabolomics exploring biomarkers in rat cerebrospinal fluid after cerebral ischemia/reperfusion | Q43567054 | ||
| Deciphering the neuroprotective mechanisms of Bu-yang Huan-wu decoction by an integrative neurofunctional and genomic approach in ischemic stroke mice | Q44925597 | ||
| The effects of Buyang Huanwu Decoction on hemorheological disorders and energy metabolism in rats with coronary heart disease | Q47295646 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neurodegeneration | Q1755122 |
| P304 | page(s) | e0209184 | |
| P577 | publication date | 2019-01-15 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Combined proteomic and metabolomic analyses of cerebrospinal fluid from mice with ischemic stroke reveals the effects of a Buyang Huanwu decoction in neurodegenerative disease | |
| P478 | volume | 14 |
Search more.